The prevalence of morbid obesity (body mass index ≥40 kg/m2) in women aged 20-39 years was 7.5% in 2009 through 2010.
Exclusion criteria were (1) ASA-PS 3 or more, (2) morbid obesity (body mass index ≥ 35 kg/m2), (3) pregnant or lactating women, (4) regular use of any Kampo medicines, and (5) use of steroids, immunosuppressive, or chemotherapy agents.
Obesity is associated with a decrease in physical QOL in a dose response relationship, while morbid obesity (Body Mass Index >40 kg/m2) has been shown to have significantly decreased mental QOL when assessed with 36-Item Short Form Health Survey compared to normal population results [9].
Surgery is considered the treatment of choice in extreme or morbid obesity (Body Mass Index - BMI≥40).
Morbid obesity (body mass index >40 kg/m).
Obesity has become a major public health problem, and the proportion of the population with morbid obesity (body mass index > 40) is increasing [ 1].
Obesity was the most frequent underlying disorder and was the only underlying disorder in 17 patients; 6 patients had morbid obesity (body mass index [BMI] >40).
Comorbid conditions potentially associated with decreased response rates included morbid obesity (body mass index (BMI)>40; 22 patients, 9%) and HIV (7 patients, 3%).
A 42 year-old white male with a past medical history significant for morbid obesity (body mass index of 41) admitted for an elective bariatric surgery, Roux-en-y gastric bypass.
Patients with diabetes mellitus, untreated hypertension, atrial fibrillation, morbid obesity (body mass index [BMI] > 35), infection, psychiatric or neurologic conditions impairing patients' ability to cooperate were excluded from the study.
